Hemophilia B treatment has greatly improved over the years, but there is still a need for longer lasting, less disruptive options. Gene therapy is an exciting new innovation for the hemophilia B community, aiming to deliver years of sustained bleed protection with a single administration.

The HemEvolution campaign offers an educational, approachable, and engaging experience conveying the value and potential benefits of gene therapy for hemophilia B, preparing the world for a treatment that could liberate patients from their condition longer than ever thought possible.